Virtual Medicinal Product (VMP) - Tiagabine 2.5mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Tiagabine 2.5mg/5ml oral suspension | Start Date 17-09-2014 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N03AG06
- BNF Codes
-
- BNF code 04080100
| Code | Start Date | End Date |
|---|---|---|
| 27441011000001106 | 17-09-2014 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Tiagabine hydrochloride monohydrate | Based on Base Substance | Tiagabine | 500 microgram | 1 ml |
Name
Tiagabine hydrochloride monohydrate
Basis of strength description
Based on Base Substance
BOSS
Tiagabine
Strength and UOM (Nmr)
500.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMTiagabine
-
VMP(Current) Tiagabine 2.5mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |